Regions Financial Corp Abbott Laboratories Transaction History

Regions Financial Corp

  • $13.8 Billion
  • Q3 2024

A detailed history of Regions Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Regions Financial Corp holds 147,131 shares of ABT stock, worth $17.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
147,131
Previous 149,061 1.29%
Holding current value
$17.3 Million
Previous $15.5 Million 8.3%
% of portfolio
0.12%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$100.07 - $118.13 $193,135 - $227,990
-1,930 Reduced 1.29%
147,131 $16.8 Million
Q2 2024

Jul 31, 2024
SELL
$100.73 - $112.44 $2.48 Million - $2.77 Million
-24,641 Reduced 14.19%
149,061 $15.5 Million
Q1 2024

Apr 23, 2024
BUY
$109.52 - $120.96 $1.5 Million - $1.66 Million
13,714 Added 8.57%
173,702 $19.7 Million
Q4 2023

Feb 06, 2024
SELL
$90.19 - $110.4 $419,203 - $513,139
-4,648 Reduced 2.82%
159,988 $17.6 Million
Q3 2023

Nov 01, 2023
SELL
$95.53 - $114.62 $102,408 - $122,872
-1,072 Reduced 0.65%
164,636 $15.9 Million
Q2 2023

Aug 09, 2023
BUY
$100.78 - $112.29 $3.19 Million - $3.56 Million
31,696 Added 23.65%
165,708 $18.1 Million
Q1 2023

May 12, 2023
SELL
$96.86 - $114.01 $424,827 - $500,047
-4,386 Reduced 3.17%
134,012 $13.6 Million
Q4 2022

Feb 03, 2023
SELL
$95.06 - $111.52 $242,973 - $285,045
-2,556 Reduced 1.81%
138,398 $15.2 Million
Q3 2022

Nov 03, 2022
SELL
$96.76 - $112.03 $725,603 - $840,112
-7,499 Reduced 5.05%
140,954 $13.6 Million
Q2 2022

Jul 25, 2022
SELL
$102.07 - $123.37 $273,955 - $331,125
-2,684 Reduced 1.78%
148,453 $16.1 Million
Q1 2022

Apr 25, 2022
SELL
$114.02 - $139.04 $139,902 - $170,602
-1,227 Reduced 0.81%
151,137 $17.9 Million
Q4 2021

Jan 31, 2022
BUY
$115.53 - $141.46 $284,203 - $347,991
2,460 Added 1.64%
152,364 $21.4 Million
Q3 2021

Nov 04, 2021
SELL
$116.66 - $129.06 $776,838 - $859,410
-6,659 Reduced 4.25%
149,904 $17.7 Million
Q2 2021

Jul 27, 2021
BUY
$105.79 - $124.53 $21,158 - $24,906
200 Added 0.13%
156,563 $18.2 Million
Q1 2021

Jun 02, 2021
SELL
$108.84 - $128.23 $520,255 - $612,939
-4,780 Reduced 2.97%
156,363 $18.7 Million
Q4 2020

Feb 05, 2021
SELL
$105.0 - $114.42 $554,505 - $604,252
-5,281 Reduced 3.17%
161,143 $17.6 Million
Q3 2020

Oct 15, 2020
SELL
$91.64 - $111.29 $713,142 - $866,058
-7,782 Reduced 4.47%
166,424 $18.1 Million
Q2 2020

Jul 27, 2020
SELL
$76.57 - $98.0 $922,668 - $1.18 Million
-12,050 Reduced 6.47%
174,206 $15.9 Million
Q1 2020

Apr 29, 2020
SELL
$62.82 - $91.86 $415,994 - $608,296
-6,622 Reduced 3.43%
186,256 $14.7 Million
Q4 2019

Feb 03, 2020
SELL
$78.51 - $87.4 $249,661 - $277,932
-3,180 Reduced 1.62%
192,878 $16.8 Million
Q3 2019

Oct 24, 2019
SELL
$81.84 - $88.74 $308,373 - $334,372
-3,768 Reduced 1.89%
196,058 $16.4 Million
Q2 2019

Jul 19, 2019
BUY
$72.88 - $85.0 $331,093 - $386,155
4,543 Added 2.33%
199,826 $16.8 Million
Q1 2019

Apr 19, 2019
SELL
$66.22 - $80.06 $522,608 - $631,833
-7,892 Reduced 3.88%
195,283 $15.6 Million
Q4 2018

Jan 28, 2019
SELL
$65.56 - $74.27 $163,506 - $185,229
-2,494 Reduced 1.21%
203,175 $14.7 Million
Q3 2018

Oct 22, 2018
BUY
$60.81 - $73.36 $244,577 - $295,053
4,022 Added 1.99%
205,669 $15.1 Million
Q2 2018

Jul 26, 2018
BUY
$57.57 - $63.54 $120,954 - $133,497
2,101 Added 1.05%
201,647 $12.3 Million
Q1 2018

Apr 18, 2018
SELL
$56.27 - $63.62 $1.02 Million - $1.15 Million
-18,131 Reduced 8.33%
199,546 $12 Million
Q4 2017

Jan 18, 2018
SELL
$53.68 - $57.47 $101,508 - $108,675
-1,891 Reduced 0.86%
217,677 $12.4 Million
Q3 2017

Oct 23, 2017
BUY
$48.06 - $53.64 $10.6 Million - $11.8 Million
219,568
219,568 $11.7 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Regions Financial Corp Portfolio

Follow Regions Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email